Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to Brazil

The import value of blood, antisera, vaccines, toxins, and cultures to Brazil was notably recorded at $3.755 billion in 2023. The forecasted trend from 2024 to 2028 shows a steady increase in import value, with year-on-year growth observed at approximately 2.54% for 2025 and 2.42% for 2026. By 2027 and 2028, the import value is expected to continue rising, maintaining a relatively consistent growth rate of around 2.32% yearly over this period. The compound annual growth rate (CAGR) from 2024 to 2028 reflects a stable average increase of 2.37% per annum.

Future trends to watch include potential impacts of policy shifts in trade agreements, advances in medical technology influencing import needs, and changes in global health trends that could affect Brazil's demand for medical imports. Monitoring these factors will be crucial for understanding long-term import dynamics.